Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -21.51M | -20.13M | -20.13M | -21.62M | |
| Total Depreciation and Amortization | 1.89M | 2.12M | 2.12M | 3.36M | |
| Total Amortization of Deferred Charges | 170.00K | 430.50K | 430.50K | 197.00K | |
| Total Other Non-Cash Items | 944.00K | 1.24M | 1.24M | 787.00K | |
| Change in Net Operating Assets | 123.00K | -1.43M | -1.43M | 1.48M | |
| Cash from Operations | -18.38M | -17.76M | -17.76M | -15.80M | |
| Capital Expenditure | -4.06M | -5.74M | -5.74M | -4.97M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | 3.00K | |
| Cash from Investing | -4.06M | -5.74M | -5.74M | -4.97M | |
| Total Debt Issued | -- | -- | -- | 0.00 | |
| Total Debt Repaid | -- | -- | -- | 0.00 | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 0.00 | 51.70M | 51.70M | 12.50M | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -119.00K | 6.14M | 6.14M | -603.00K | |
| Cash from Financing | -119.00K | 57.84M | 57.84M | 11.90M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -22.57M | 34.33M | 34.33M | -8.86M | |